Targeting the tripartite axis of immune-metabolic-spatial crosstalk to overcome therapy resistance in breast cancer.
Saved in:
| Title: | Targeting the tripartite axis of immune-metabolic-spatial crosstalk to overcome therapy resistance in breast cancer. |
|---|---|
| Authors: | He S; Department of Pathology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.; Key Laboratory of Intelligent and Precision Pathology Diagnosis in Oncology, China Medical University, Shenyang, Liaoning, China., Liu X; Department of Pathology, Liaoning Health Industry Group Bengang General Hospital, Benxi, Liaoning, China., Lv Q; Department of Pathology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.; Key Laboratory of Intelligent and Precision Pathology Diagnosis in Oncology, China Medical University, Shenyang, Liaoning, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Mar 23; Vol. 17, pp. 1748257. Date of Electronic Publication: 2026 Mar 23 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
